30

2018-06


International Cooperation Project

Partner: U.S. National Institutes of Health Project Leader: Bovine rotavirus vaccine Collaboration Model: Technical cooperation, supported by the Ministry of Science and Technology’s first batch of special funds for international science and technology cooperation and exchange in 2011 Partner: Sanofi Pasteur, France Project Leader: Diploid cell–based rabies vaccine Collaboration Model: Technology transfer, supported by the Ministry of Science and Technology’s first batch of special funds for international science and technology cooperation and exchange in 2011 Significance of the collaboration: This marks China’s second project to introduce a complete set of vaccine production technologies. Partner: INTRAVACC, Netherlands Project Leader: Diploid cell–based rabies vaccine Collaboration Model: Technology transfer, supported by the Ministry of Science and Technology’s first batch of special funds for international science and technology cooperation and exchange in 2011.

30

2018-06


Human–Bovine Rotavirus Vaccine Project

Partner: National Institutes of Health, USA; Project Leader: Bovine Rotavirus Vaccine; Cooperation Model: Technical Collaboration; Supported by the Ministry of Science and Technology’s first batch of special funds for international scientific and technological cooperation and exchange in 2011.

30

2018-06


Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae) Project

Partner: Merck, USA Project: Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae) Cooperation Model: Technology Transfer Significance: China’s first complete vaccine‑production technology, filling a domestic gap in this field.

< 12 >